Related scientific articles (all)

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells.

Authors : Najar M, Fayyad-Kazan M, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Year : 2016
Journal : Data Brief
Volume : 8
Pages : 1111-4

Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge.

Authors : Kourie HR, Tabchi S, Kattan J
Year : 2016
Journal : Future Oncol
Volume : 12(12)
Pages : 1435-7

The Future of Access to Innovative Medicines in Cancer Therapy: Towards Conditional Dialogue Fostering Affordable Therapeutic Innovation

Authors : van Dyk N, De Greve J, Schots R, Awada A, Van Eycken L, Geldof T
Year : 2016
Journal : Vlerick business school
Volume : 7
Pages : -

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

Authors : Morgan G, Lambertini M, Kourie HR, Amaral T, Argiles G, Banerjee S, Cardone C, Corral J, De Mattos-Arruda L, Öztürk A, Petrova M, Poulsen L, Strijbos M, Tyulyandina A, Vidra R, Califano R, de Azambuja E, Garrido Lopez P, Guarneri V, Reck M, Moiseyenko V, Martinelli E, Douillard JY, Stahel R, Voest E, Arnold D, Cardoso F, Casali P, Cervantes A, Eggermont AM, Eniu A, Jassem J, Pentheroudakis G, Peters S, McGregor K, Rauh S, Zielinski CC, Ciardiello F, Tabernero J, Preusser M
Year : 2016
Journal : ESMO Open
Volume : 1
Pages : e000107

Breast cancer in 2015: Academic research sheds light on issues that matter to patients.

Authors : Piccart-Gebhart M, Gingras I
Year : 2016
Journal : Nat Rev Clin Oncol
Volume : 13
Pages : 67-8

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be th

Authors : Viale G, Slaets L, de Snoo FA, Bogaerts J, Russo L, van t Veer L, Rutgers E, Piccart-Gebhart M, Stork-Sloots L, Dell orto P, Glas A, Cardoso F
Year : 2016
Journal : Breast Cancer Res Treat
Volume : 155(3)
Pages : 463-9

Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.

Authors : Roufosse F, Heimann P, Lambert F, Sidon P, Bron D, Cottin V, Cordier JF
Year : 2016
Journal : Respiration
Volume : 91
Pages : 374-9

Survey on skin-lightening practices and cosmetics in Kigali, Rwanda.

Authors : Kamagaju L, Morandini R, Gahongayire F, Stévigny C, Ghanem G, Pirotte G, Duez P
Year : 2016
Journal : Int J Dermatol
Volume : 55(1)
Pages : 45-51

Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.

Authors : Goris Gbenou MC, Peltier A, Schulman CC, Velthoven Rv
Year : 2016
Journal : Urol Oncol
Volume : 34(6)
Pages : 254.e1-6

Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?

Authors : Lewalle P, Wittnebel S
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 390-7

EGFR mutation status on brain metastases from non-small cell lung cancer.

Authors : Hsu F, De Caluwe A, Anderson D, Nichol A, Toriumi T, Ho C
Year : 2016
Journal : Lung Cancer
Volume : 96
Pages : 101-7

Progressive multifocal leukoencephalopathy mimicking cerebral metastases in a patient treated for nasopharyngeal carcinoma

Authors : Oualla K, Aoun F, Lemort M, Harrouk A, Latifyan S, Awada A, Georgala A
Year : 2016
Journal : Belgian J Medical Oncology
Volume : 10(7)
Pages : 276-280

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Authors : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EGE, Piccart-Gebhart M
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 205-207

Characterization of human breast cancer tissues by infrared imaging.

Authors : Verdonck M, Denayer A, Delvaux B, Garaud S, de Wind R, Desmedt C, Sotiriou C, Willard-Gallo K, Goormaghtigh E
Year : 2016
Journal : Analyst
Volume : 141(2)
Pages : 606-19

Catalog of genetic progression of human cancers: breast cancer.

Authors : Desmedt C, Yates L, Kulka J
Year : 2016
Journal : Cancer Metastasis Rev
Volume : 35(1)
Pages : 49-62

Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

Authors : Kourie HR, Awada G, Awada A
Year : 2016
Journal : Future Oncol
Volume : 12(4)
Pages : 429-31

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.

Authors : Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van der Smissen WJ, Vlugt-Daane MV, van Galen A, Nik-Zainal S, Staaf J, Brinkman AB, Van de Vijver MJ, Richardson AL, Fatima A, Berentsen K, Butler A, Martin S, Davies HR, Debets R, Gelder ME, van Deurzen CH, Macgrogan G, Van den Eynden GG, Purdie C, Thompson AM, Caldas C, Span PN, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Ringnér M, Tommasi S, Eyford J, Broeks A, Vincent-Salomon A, Futreal PA, Knappskog S, King T, Thomas G, Viari A, Langerød A, Børresen-Dale AL, Birney E, Stunnenberg HG, Stratton M, Foekens JA, Martens JW
Year : 2016
Journal : Nat Commun
Volume : 7
Pages : 12910

Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance.

Authors : Berns K, Sonnenblick A, Gennissen A, Brohée S, Hijmans ME, Evers B, Fumagalli D, Desmedt C, Loibl S, Denkert C, Neven P, Guo W, Zhang F, Knijnenburg TA, Bosse T, van der Heijden MS, Hindriksen S, Nijkamp W, Wessels LF, Joensuu H, Mills GB, Beijersbergen RL, Sotiriou C, Bernards R
Year : 2016
Journal : Clin Cancer Res
Volume : 22(21)
Pages : 5238-48

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Authors : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Year : 2016
Journal : Cytotherapy
Volume : 18
Pages : 320-35

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.

Authors : Liberale G, El Houkayem M, Viste C, Bouazza F, Moreau M, El Nakadi I, Veys I
Year : 2016
Journal : Support Care Cancer
Volume : 24(12)
Pages : 5035-40